History remembers breakthroughs.
It rarely remembers the circumstances that produced them.
Take penicillin. Most people know Alexander Fleming. Few know the years of work that followed before it became a usable medicine. The same is true for artemisinin, one of the world's most effective antimalarial drugs. The name Tu Youyou only entered public conversation after she received the Nobel Prize in 2015. But the story began almost half a century earlier, behind closed doors in Mao-era China.
In 1969, China was in the middle of the Cultural Revolution. Universities were disrupted, scientists faced political scrutiny, and the country was largely cut off from the West. At the same time, malaria was devastating troops fighting in the Vietnam War. Existing medicines were losing their effectiveness as the parasite developed resistance.
China responded by launching a classified military research programme known as Project 523, named after its start date- 23 May 1967. More than 500 researchers from around 60 institutions were brought together with one objective: find a new treatment for malaria.
Among them was Tu Youyou.
Unlike many scientists who later became internationally known, Tu did not have a doctoral degree or overseas research experience. She had trained in pharmaceutical sciences and spent years studying traditional Chinese medicine. It was hardly the profile of someone expected to make one of the century's biggest medical discoveries.
Her breakthrough didn't begin in a laboratory.
It began in an old book.
While reviewing ancient medical texts, Tu came across a fourth-century manuscript by physician Ge Hong. One passage described using qinghao, or sweet wormwood, to treat recurring fevers. Earlier attempts to test the plant had failed because researchers boiled it at high temperatures, destroying the active compound without realising it.
The ancient text suggested something different.
Instead of boiling the herb, it recommended soaking and squeezing it.
Tu wondered whether the extraction method, not the plant itself, was the missing piece.
Her team changed course. They used a low-temperature extraction process, preserving the active ingredient that would later be identified as artemisinin.
The results were unlike anything they had seen before.
Laboratory tests showed remarkable success against the malaria parasite. Before large-scale clinical trials became possible, Tu and several colleagues reportedly tested the extract on themselves to observe whether it caused harmful side effects, a decision that reflected the urgency of the mission and the limited research infrastructure available at the time.
The medicine that emerged from that work has since saved millions of lives, particularly in Africa and Asia, where malaria remains one of the world's deadliest infectious diseases. Today, artemisinin-based combination therapies are recommended by the World Health Organisation as the standard treatment for Plasmodium falciparum malaria.
Yet science was only part of the story.
When Tu Youyou received the Nobel Prize in Physiology or Medicine in 2015, she became the first Chinese scientist to win the award for research carried out entirely within China.
The honour was celebrated across the country.
It also reopened an old debate.
Project 523 had never been the work of one individual. Hundreds of researchers contributed over several years. Many in China argued that the Nobel Prize, by recognising a single scientist, reflected a Western tradition of celebrating individual achievement rather than collective effort.
Others responded that every major scientific project has countless contributors, but transformative discoveries often have someone whose insight changes the direction of the research.
Both arguments have merit.
Scientific discoveries rarely emerge from isolated brilliance alone. They depend on laboratories, technicians, funding, collaboration and years of incremental work. At the same time, moments of originality often come from individuals willing to question accepted methods.
Tu Youyou did exactly that.
She looked at a failed experiment, revisited a text written more than 1,700 years earlier and asked whether modern science had overlooked something hidden in plain sight.
That question changed medicine.
Today, artemisinin remains one of the most important weapons against malaria. Millions of patients have benefited from a discovery that began with an ancient manuscript, a classified government project and a scientist who spent years working without international recognition.
The story reminds us that scientific progress doesn't always follow a straight line.
Sometimes it moves forward by looking back.
References:
- The Nobel Prize – Nobel Prize in Physiology or Medicine 2015: Tu Youyou.
- World Health Organisation (WHO) – Artemisinin-based Combination Therapies (ACTs) for malaria treatment.
- Tu Youyou (2016), Discovery of Artemisinin (Qinghaosu) and Gifts from Chinese Medicine, Nature Medicine.
. . .